Advanced search
Publication Cover
Acta Oncologica Volume 28, 1989 - Issue 3
Journal homepage
247
Views
49
CrossRef citations to date
0
Altmetric
Original Article

Medical Treatment of Neuroendocrine Gut and Pancreatic Tumors

K. Ouberg FROM THE LUDWIG INSTITUTE FOR CANCER RESEARCH, UNIVERSITY HOSPITAL, S-75185, UPPSALA, SWEDEN
&
B. Eriksson FROM THE LUDWIG INSTITUTE FOR CANCER RESEARCH, UNIVERSITY HOSPITAL, S-75185, UPPSALA, SWEDEN
Pages 425-431 | Published online: 08 Jul 2009

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Jennifer A Chan$suffix/text()$suffix/text() & Matthew H Kulke$suffix/text()$suffix/text(). (2007) Emerging therapies for the treatment of patients with advanced neuroendocrine tumors. Expert Opinion on Emerging Drugs 12:2, pages 253-270.
Read now
Hassan Imam, Barbro Eriksson, Agneta Lukinius, Eva T. Janson, Per-Gunnar Lindgren, Erik Wilander & Kjell Öberg. (1997) Induction of Apoptosis in Neuroendocrine Tumors of the Digestive System During Treatment with Somatostatin Analogs. Acta Oncologica 36:6, pages 607-614.
Read now
M. B. Jacobsen, L. E. Hanssen, F. Kolmannskog, E. Schrumpf, M. H. Vatn & A. Bergan. (1995) Interferon-α2b, with or without Prior Hepatic Artery Embolization: Clinical Response and Survival in Mid-Gut Carcinoid Patients: The Norwegian Carcinoid Study. Scandinavian Journal of Gastroenterology 30:8, pages 789-796.
Read now
Barbro Eriksson, Mats Bergström, Anders Lilja, Håkan Ahlström, Bengt Långström & Kjell Öberg. (1993) Positron Emission Tomography (PET) in Neuroendocrine Gastrointestinal Tumors. Acta Oncologica 32:2, pages 189-196.
Read now
W. Creutzfeldt, H. H. Bartsch, U. Jacubaschke & F. Stöckmann. (1991) Treatment of Gastrointestinal Endocrine Tumours with Interferon-α and Octreotide. Acta Oncologica 30:4, pages 529-535.
Read now
K. Öberg & B. Eriksson. (1991) The Role of Interferons in the Management of Carcinoid Tumors. Acta Oncologica 30:4, pages 519-522.
Read now
C. B. H. W. Lamers. (1991) Gastrinoma in Multiple Endocrine Neoplasia Type 1. Acta Oncologica 30:4, pages 489-492.
Read now

Articles from other publishers (42)

Ammar Asban, Anish J. Patel, Sushanth Reddy, Thomas Wang, Courtney J. Balentine & Herbert Chen. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1074 1107.e11 .
David F. Schneider, Haggi Mazeh, Sam J. Lubner, Juan C. Jaume & Herbert Chen. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1112 1142.e7 .
Trude Haugland, Marijke Veenstra, Morten H. Vatn & Astrid K. Wahl. (2013) Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study. Nursing Research and Practice 2013, pages 1-9.
Crossref
Sowon Oh, Vikas Prasad, Dong Soo Lee & R. P. Baum. (2011) Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT. International Journal of Molecular Imaging 2011, pages 1-7.
Crossref
Aejaz Nasir, James Helm, Leslie Turner, Dung-Tsa Chen, Jonathan Strosberg, Naiel Hafez, Evita B. Henderson-Jackson, Pamela Hodul, Marilyn M. Bui, Nelly A. Nasir, Ardeshir Hakam, Mokenge P. Malafa, Timothy J. Yeatman, Domenico Coppola & Larry K. Kvols. (2011) RUNX1T1. Pancreas 40:4, pages 627-633.
Crossref
Steven C. Katz, Charan Donkor, Kristen Glasgow, Venu G. Pillarisetty, Mithat Gönen, N. Joseph Espat, David S. Klimstra, Michael I. D'Angelica, Peter J. Allen, William Jarnagin, Ronald P. DeMatteo, Murray F. Brennan & Laura H. Tang. (2010) T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. HPB 12:10, pages 674-683.
Crossref
Trude Haugland, Morten H. Vatn, Marijke Veenstra, Astrid Klopstad Wahl & Gerd Karin Natvig. (2009) Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population. Quality of Life Research 18:6, pages 719-726.
Crossref
Cristina R. Ferrone, Laura H. Tang, James Tomlinson, Mithat Gonen, Steven N. Hochwald, Murray F. Brennan, David S. Klimstra & Peter J. Allen. (2007) Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?. Journal of Clinical Oncology 25:35, pages 5609-5615.
Crossref
U. Plöckinger & B. Wiedenmann. (2007) Treatment of gastroenteropancreatic neuroendocrine tumors. Virchows Archiv 451:S1, pages 71-80.
Crossref
Kong Teng Tan & John R. Kachura. 2006. Vascular Embolotherapy. Vascular Embolotherapy 177 188 .
Gerard M. Doherty. (2005) Rare endocrine tumours of the GI tract. Best Practice & Research Clinical Gastroenterology 19:5, pages 807-817.
Crossref
Matthew Kulke. (2005) Advances in the treatment of neuroendocrine tumors. Current Treatment Options in Oncology 6:5, pages 397-409.
Crossref
P. Del Monte, C. Laurino, M. Arvigo, C. Palermo, F. Minuto & A. Barreca. (2014) Effects of α-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. Journal of Endocrinological Investigation 28:7, pages 432-439.
Crossref
M. Pellis Urquiza, A. Blasco Pelcano & F. Rodrguez Moranta. (2004) Otras neoplasias g?stricas. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:2, pages 119-125.
Crossref
Matthew H Kulke. (2003) Neuroendocrine tumours: clinical presentation and management of localized disease. Cancer Treatment Reviews 29:5, pages 363-370.
Crossref
G D Slooter, A Mearadji, W A P Breeman, R L Marquet, M de Jong, E P Krenning & C H J van Eijck. (2001) Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours. British Journal of Surgery 88:1, pages 31-40.
Crossref
Christophe Cellier, Cesar Yaghi, Emmanuel Cuillerier, Nathalie Siauve, Anne Berger, Francoise Carnot, Charles Haddad, Jean Philippe Barbier & Bruno Landi. (2000) Metastatic jejunal VIPoma: beneficial effect of combination therapy with interferon-alpha and 5-fluorouracil. The American Journal of Gastroenterology 95:1, pages 289-293.
Crossref
Anders Sundin, Barbro Eriksson, Mats Bergström, Peter Bjurling, Karl-Johan Lindner, Kjell Öberg & Bengt Långström. (2000) Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography. Nuclear Medicine and Biology 27:1, pages 33-41.
Crossref
G. Larsson, P.O. Sjödén, K. Öberg & L. von Essen. (1999) Importance-satisfaction discrepancies are associated with health-related quality of life in five-year survivors of endocrine gastrointestinal tumours. Annals of Oncology 10:11, pages 1321-1327.
Crossref
N.S. Reed. (1999) Management of Neuroendocrine Tumours. Clinical Oncology 11:5, pages 295-302.
Crossref
C.H.J. van Eijck, M. de Jong, W.A.P. Breeman, G.D. Slooter, R.L. Marquet & E.P. Krenning. (1999) Somatostatin receptor imaging and therapy of pancreatic endocrine tumors. Annals of Oncology 10, pages S177-S181.
Crossref
Gunnel Larsson, Louise von Essen & Per-Olow Sj??d??n. (1998) Quality of life in patients with endocrine tumors of the gastrointestinal tract: Patient and staff perceptions. Cancer Nursing 21:6, pages 411-420.
Crossref
DINO SGARABOTTO, FABRIZIO VIANELLO, PIERO M. STEFANI, FABIO SCANO, ROBERTO SARTORI, ANDREA CAENAZZO & ANTONIO GIROLAMI. (1997) Hypertriglyceridemia During Long-Term Interferon-α Therapy in a Series of Hematologic Patients. Journal of Interferon & Cytokine Research 17:5, pages 241-244.
Crossref
S. Janmohamed & S. R. Bloom. (1997) Carcinoid tumours.. Postgraduate Medical Journal 73:858, pages 207-214.
Crossref
John F. Sweeney & Alexander S. Rosemurgy. (2017) Carcinoid Tumors of the Gut. Cancer Control 4:1, pages 18-24.
Crossref
A. J. Scheen & P. J. Lefèbvre. 1996. Glucagon III. Glucagon III 239 254 .
G. C. Viscomi, M. Grimaldi, E. Palazzini & S. Silvestri. (2006) Human leukocyte interferon alpha: Structure, pharmacology, and therapeutic applications. Medicinal Research Reviews 15:5, pages 445-478.
Crossref
A. G. HARRIS & J. S. REDFERN. (2007) Octreotide treatment of carcinoid syndrome: analysis of published dose‐titration data. Alimentary Pharmacology & Therapeutics 9:4, pages 387-394.
Crossref
Enzo Soresi, Giovanni Invernizzi, Roberto Boffi, Umberto Borghini, Gianfranco Schiraldi, Paolo Valerio Mantellini, Giovanni Gramegna & Antonio Liuzzi. (2018) Effect of Octreotide on Neuroenolase Levels in Patients with Small Cell Lung Cancer. Tumori Journal 80:5, pages 332-334.
Crossref
BARBRO ERIKSSON, A. LILJA, H. AHLSTRÖM, P. BJURLING, M. BERGSTRÖM, K.J. LINDNER, B. LÅNGSTRÖM & KJELL ÖBERG. (1994) Positron-Emission Tomography as a Radiological Technique in Neuroendocrine Gastrointestinal Tumors. Annals of the New York Academy of Sciences 733:1 Molecular and, pages 446-452.
Crossref
B. MARK EVERS, JIN ISHIZUKA, COURTNEY M. TOWNSEND & JAMES C. THOMPSON. (1994) The Human Carcinoid Cell Line, BON.. Annals of the New York Academy of Sciences 733:1 Molecular and, pages 393-406.
Crossref
J. Gregory McKinnon. (2006) Palliative treatment of neuroendocrine tumors. Seminars in Surgical Oncology 9:5, pages 453-458.
Crossref
Stefan Einhorn & Hans Strander. (1993) Interferon treatment of human malignancies - a short review. Medical Oncology and Tumor Pharmacotherapy 10:1-2, pages 25-29.
Crossref
K. Öberg. 1993. Molecular Oncology and Clinical Applications. Molecular Oncology and Clinical Applications 363 374 .
Alfredo BerrutiGabriella GorzegnoGraziella VitettaMarco TampelliniLuigi Dogliotti. (2018) Hypertriglyceridemia during Long-Term Interferon-Alpha Therapy: Efficacy of Diet and Gemfibrosil Treatment. A Case Report. Tumori Journal 78:5, pages 353-355.
Crossref
Heikki Joensuu, Eero Kumpulainen & Pentti Gröhn. (1992) Treatment of metastatic carcinoid tumour with recombinant interferon alfa. European Journal of Cancer 28:10, pages 1650-1653.
Crossref
Li-Teh Wu & Steven D. Averbuch. 1992. Malignant Tumors of the Thyroid. Malignant Tumors of the Thyroid 204 214 .
Erik Hippe, Viggo Jønsson, Hans von der Maase, Jens Christian Mathiesen & Hans Skovgaard Poulsen. (1991) Homoeostatic response criteria for cancer therapy. European Journal of Cancer and Clinical Oncology 27:12, pages 1715-1716.
Crossref
K. Öberg & B. Eriksson. (1991) The role of interferons in the management of carcinoid tumours. British Journal of Haematology 79:s1, pages 74-77.
Crossref
Kjell E. Öberg. 1991. Interferons: Mechanisms of Action and Role in Cancer Therapy. Interferons: Mechanisms of Action and Role in Cancer Therapy 43 52 .
R. ARNOLD. (2008) Therapeutic strategies in the management of endocrine GEP tumours. European Journal of Clinical Investigation 20:1, pages 82-90.
Crossref
Jerome M. Feldman. (1989) Carcinoid tumors and the carcinoid syndrome. Current Problems in Surgery 26:12, pages 835-885.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.